Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 16Recruiting 7Active not recruiting 4Not yet recruiting 3Unknown 1Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 21Gastrointestinal 10Thoracic 6Gynecologic 5Genitourinary 5Tumor-Agnostic 4Other hematologic neoplasm 4Other 3Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 1Motor Activity 1Lymphoma 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Fatigue 1

Interventions

Cyclophosphamide 139Rituximab 115Etoposide 77Vincristine 75Doxorubicin 62Cytarabine 61Dexamethasone 58Prednisone 55fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 37Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22fludarabine phosphate 20Busulfan 20Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17ibrutinib 16Decitabine 16Carmustine 16Mercaptopurine 15Filgrastim 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Exercise × Lymphoid × Clear all
NCT00884364 2009-12-23

Exercise During Chemotherapy for Patients With Hematological Malignancies

Charite University, Berlin, Germany

Phase 3 Unknown
60 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Fatigue, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Motor Activity, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡